Absolute drug bioavailability II: Evaluation of renal clearance perturbation method using literature data assuring a fraction absorbed of unity.
作者信息
Lalka D, du Souich P, McLean A J, Gibaldi M
出版信息
J Pharm Sci. 1978 Apr;67(4):591-2. doi: 10.1002/jps.2600670449.
PMID:641784
Abstract
摘要
相似文献
1
Absolute drug bioavailability II: Evaluation of renal clearance perturbation method using literature data assuring a fraction absorbed of unity.
J Pharm Sci. 1978 Apr;67(4):591-2. doi: 10.1002/jps.2600670449.
2
[Bioavailability and biopharmaceutics].[生物利用度与生物药剂学]
Boll Chim Farm. 1976 Mar;115(3):231-41.
3
An overview of the analysis and interpretation of bioavailability studies in man.人体生物利用度研究的分析与解读概述。
Arzneimittelforschung. 1976;26(1A):105-8.
4
Bioavailability and pharmacokinetic analysis of drug responding systems.药物反应系统的生物利用度和药代动力学分析。
Annu Rev Pharmacol Toxicol. 1978;18:495-522. doi: 10.1146/annurev.pa.18.040178.002431.
5
[Pharmacokinetic aspects relevant to biopharmaceutics].[与生物药剂学相关的药代动力学方面]
Ann Ist Super Sanita. 1982;18(3):533-40.
6
Clearance concepts in pharmacokinetics.药代动力学中的清除概念。
J Pharmacokinet Biopharm. 1973 Apr;1(2):123-36. doi: 10.1007/BF01059626.
7
Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and procedures.
J Pharmacokinet Biopharm. 1976 Aug;4(4):337-53. doi: 10.1007/BF01063123.
8
Letter: Absolute drug bioavailability: approximation without comparison to parenteral dose for compounds exhibiting perturbable renal clearance.信函：绝对药物生物利用度：对于表现出可干扰肾清除率的化合物，无需与肠胃外给药剂量进行比较即可估算。
J Pharm Sci. 1974 Nov;63(11):1812. doi: 10.1002/jps.2600631140.
9
Bioavailability under variable renal clearance conditions.
J Pharm Sci. 1979 Jan;68(1):128-9. doi: 10.1002/jps.2600680148.
10
Predicting the impact of physiological and biochemical processes on oral drug bioavailability.预测生理和生化过程对口服药物生物利用度的影响。
Adv Drug Deliv Rev. 2001 Oct 1;50 Suppl 1:S41-67. doi: 10.1016/s0169-409x(01)00179-x.
Zotero 插件